CureMover is the UK's first autonomous pharmaceutical transport platform — combining real-time environmental control, vibration protection, and blockchain-backed compliance in one device.
Lost annually to the NHS due to medicine wastage and cold-chain failures.
Current cold-chain tooling only records damage after the fact. By the time a breach is discovered, the medicine — and the batch — is already lost.
High-value medicines travel with no physical protection layer. Diverted or tampered shipments enter the supply chain undetected.
Paper logs and fragmented spreadsheets consume staff hours, invite human error, and collapse under MHRA and GDP audit scrutiny.
Existing devices react — they never anticipate. Route risk, weather exposure, and equipment fatigue stay invisible until failure happens.
Set drug-specific thresholds — temperature band, humidity ceiling, vibration and shock tolerance — in minutes. Each shipment carries its own stability profile.
App SetupNine calibrated sensors track temperature, humidity, light, vibration, GPS and physical access — every second, throughout transit.
Real-TimeWhen any parameter drifts, the system autonomously activates cooling, heating, humidity control or vibration dampening — no human required.
Autonomous AIEvery event is recorded on blockchain and auto-structured into a regulator-ready report for MHRA, GDP and FDA submissions.
BlockchainSix proprietary interventions that set CureMover apart from every data-logger and passive monitor on the market.
Integrated micro-cooling and heating elements restore in-range conditions the moment a drift begins — before an excursion is ever logged.
Patentable InventionAdaptive dampening protects biologics, vaccines and sensitive compounds from road shock and handling stress in real time.
Industry FirstEnclosure sensors detect unauthorised opening, cutting or removal — triggering instant alerts and an immutable security record.
Security LayerGPS combined with weather and traffic intelligence flags high-risk corridors and prolonged exposure windows before they cause a loss.
AI ResearchAll sensor and intervention events are chained to a tamper-resistant ledger and auto-formatted for MHRA, GDP and FDA submissions.
Audit-ReadyMolecule-level degradation thresholds drive device behaviour, so each shipment is calibrated to the exact product it protects.
Precision ControlCureMover's stack contains no speculative components — every component is grounded in peer-reviewed research and industry-validated engineering.
The nine-sensor edge array, closed-loop thermal control, adaptive vibration dampening, MHRA-based motion analysis and AI-powered prediction all feed one unified data plane.
Communication is secured via AES-256 encryption, compliant with ISO 27001 and GDPR at every layer. Data is transmitted over 4G/5G and stored in encrypted cloud infrastructure with blockchain chain-of-custody logging.
Temperature, humidity, light, vibration, GPS — calibrated and drift-tested.
Anomaly detection, predictive maintenance, risk-probability estimation.
Real-time processing, cloud-hosted dashboarding, event-based alerting.
Immutable chain of custody for every shipment, tamper-proof.
Seamless transmission from UK and EU corridors, offline caching fallback.
ISO 27001 and GDPR compliant at every layer, edge to cloud.
NHS trusts, distributors & manufacturers
The autonomous transport device itself — nine-sensor array, GPS, vibration dampening and thermal elements — ready for day one.
Unlock the full CureMover intelligence layer — predictive analytics, live reporting, and molecule-level stability profiling.
Keep every device certified, calibrated and fully audit-ready — with a guaranteed maintenance and validation cycle.
The UK pharmaceutical logistics market was valued at USD 4.8 billion in 2024 and is projected to reach USD 9.4 billion by 2030 at a 10% CAGR — driven by biologics, vaccines and advanced-therapy volumes.
The cold-chain segment alone is forecast to grow at 5.5% CAGR from 2025 to 2031 — with GDP monitoring, real-time tracking and intelligent control storage as the primary growth drivers.
Yet current UK provider standards assume passive environmental correction, vibration protection and predictive AI in a single portable device. That is the gap CureMover fills.
Get in TouchPhD in Pharmaceutical Sciences with domain expertise spanning drug stability, MHRA and regulatory frameworks, cold-chain validation and quality assurance across the pharmaceutical supply chain.
Leads clinical and regulatory strategy — translating scientific stability requirements into the economic foundation for CureMover's molecule-level protection engine.
Computer engineer and MSc Computer Science graduate. Currently IT Support Analyst at Islington Council, providing enterprise infrastructure support within GDPR-compliant environments involving sensitive surveillance data and audit-ready evidence and secure data handling.
Hands-on capabilities in full-stack development, IoT systems, blockchain, AI-driven subsystems and cloud infrastructure — direct application to CureMover's technical roadmap.
Whether you are an NHS trust, pharmaceutical manufacturer, logistics provider or hospital — book a demonstration and see CureMover in action.